VIGORITA, Maria
 Distribuzione geografica
Continente #
NA - Nord America 1.661
EU - Europa 1.358
AS - Asia 571
SA - Sud America 346
AF - Africa 21
OC - Oceania 1
Totale 3.958
Nazione #
US - Stati Uniti d'America 1.648
IE - Irlanda 400
SE - Svezia 383
BR - Brasile 320
SG - Singapore 247
CN - Cina 219
UA - Ucraina 196
DE - Germania 130
FI - Finlandia 66
IT - Italia 59
GB - Regno Unito 53
IN - India 25
RU - Federazione Russa 19
FR - Francia 17
HK - Hong Kong 12
IR - Iran 12
UZ - Uzbekistan 11
AR - Argentina 9
BE - Belgio 8
TR - Turchia 8
IQ - Iraq 7
MX - Messico 7
CZ - Repubblica Ceca 6
MA - Marocco 6
VE - Venezuela 6
GR - Grecia 5
BD - Bangladesh 4
JO - Giordania 4
ZA - Sudafrica 4
CA - Canada 3
KE - Kenya 3
LB - Libano 3
NO - Norvegia 3
PT - Portogallo 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CO - Colombia 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
NG - Nigeria 2
OM - Oman 2
PH - Filippine 2
PL - Polonia 2
SA - Arabia Saudita 2
VN - Vietnam 2
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CH - Svizzera 1
CL - Cile 1
GT - Guatemala 1
HR - Croazia 1
ID - Indonesia 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
NL - Olanda 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 3.958
Città #
Dublin 399
Jacksonville 352
Chandler 275
Nyköping 265
Dearborn 188
Singapore 138
Beijing 79
Cambridge 61
Medford 61
Princeton 61
Ann Arbor 45
Ashburn 44
Boardman 40
The Dalles 40
Des Moines 37
Jinan 26
Lancaster 21
San Mateo 21
São Paulo 21
Haikou 12
Hong Kong 12
New York 12
Woodbridge 12
Belo Horizonte 11
Ardabil 10
Los Angeles 10
Rio de Janeiro 10
Shenyang 10
Tashkent 10
Wilmington 10
Brasília 9
Nanchang 9
Tianjin 9
Brussels 8
Nanjing 8
Bremen 6
Guangzhou 6
Hebei 6
Seattle 6
Turin 6
Baghdad 5
Brno 5
Changsha 5
Curitiba 5
Fuzhou 5
Guarulhos 5
Hangzhou 5
Monmouth Junction 5
Ningbo 5
Pune 5
Sorocaba 5
Taiyuan 5
Taizhou 5
Amman 4
Augusta 4
Contagem 4
Frankfurt am Main 4
Goiânia 4
Helsinki 4
Houston 4
Istanbul 4
Milan 4
Mumbai 4
Norwalk 4
Washington 4
Zhengzhou 4
Anápolis 3
Asunción 3
Dhaka 3
Düsseldorf 3
Florianópolis 3
Hefei 3
Hortolândia 3
Hyderabad 3
Manaus 3
Mountain View 3
Nizhniy Novgorod 3
Nocera Terinese 3
Pietra Ligure 3
Porto Alegre 3
Praia Grande 3
Riva 3
Saint Petersburg 3
Santa Isabel 3
Santo André 3
Volta Redonda 3
Auburn Hills 2
Betim 2
Breganze 2
Camaçari 2
Campina Grande 2
Campinas 2
Campo Maior 2
Caraguatatuba 2
Caçapava 2
Clearwater 2
Córdoba 2
Dubai 2
Guaíba 2
Ho Chi Minh City 2
Totale 2.571
Nome #
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 99
4-Carbossiamido-9-fluorenoni: proprietà anti-HSV-2 e immunostimolanti 93
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 92
FLUOROCONTAINING D-CYCLOSERINES - SYNTHESIS AND INVITRO EVALUATION OF ANTIMICROBIAL AND ANTIVIRAL ACTIVITIES 92
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 88
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 87
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 86
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 84
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 81
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 81
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 80
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 80
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 79
9-fluorenon-4-carboxamides: synthesis, conformational analysis, anti-HSV-2, and immunomodulatory evaluation. Note II 79
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 79
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 79
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 78
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 77
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 76
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 73
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 71
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 70
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 69
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 68
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 67
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 67
Biocatalysed synthesis of beta-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties 66
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 64
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 63
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 63
Design and synthesis of DNA-intercalating 9-fluoren-beta-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents 63
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 62
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 62
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 62
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 61
In vitro Antimycobacterial Activity of Isoniazid-related Metalchelates 61
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 61
Risonanza magnetica nucleare di 1,4-benzodiazepine. Accoppiamento attraverso lo spazio di 2,3-diidro-1H-1,4-benzodiazepine 1-sostituite 61
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 59
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 57
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 57
Nuclear magnetic resonance of psychotherapeutic agents. IV. Conformational analysis of 2,3-dihydro.1H-1,4-benzodiazepines 57
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 56
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 55
Halogenated isoniazid derivatives .6. Evaluation of anti-HSV-1 and anti-HIV-1 in vitro activities of fluorinated analogues 55
Nuclear magnetic resonance spectra of psychotherapeutic agents. V. Conformational analysis of 1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-ones 55
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 55
Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI. 54
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 54
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 52
Sintesi, attività in vitro e SARs di 2,4-tiazolidindioni inibitori dell'aldoso reduttasi 51
Nuclear magnetic resonance of 1,4-benzodiazepines. II. Stereochemistry of 1,3-dihydro-2H-1,4-benzodiazepin-2-ones by lanthanide shift reagents 51
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 49
Isonicotinoilidrazoni fluorurati: reattività ed attività antimicobatterica ed anti-HIV 48
Isonicotinoilidrazoni: reattività con diazometano ed attività antimicobatterica ed anti-HIV 47
Tetraplex DNA specific ligand based on the fluorenone-carboxamide scaffold. 46
In Vitro Aldose Reductase Inhibitory Activity of 5-Benzyl-2,4-thiazolidinediones 46
Nuclear magnetic resonance spectra of psychotherapeutic agents. III. Stereochemistry of 1-methyl5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-2,4-diones 42
Metal(II) complexes with isoniazid analogues: synthesis and pharmacological activity 38
Metalchelati di aroilidrazoni. Sintesi e valutazione dell'attività antitubercolare 35
Reattività di isonicotinoilidrazoni con diazometano 35
Totale 3.978
Categoria #
all - tutte 16.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.285


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202075 0 0 0 0 0 0 0 0 0 0 74 1
2020/2021393 53 5 73 13 13 50 5 49 1 53 67 11
2021/2022413 6 94 3 10 22 0 27 14 6 27 70 134
2022/20231.161 94 130 57 100 76 118 27 57 476 9 17 0
2023/2024204 16 34 32 13 24 42 1 13 0 3 0 26
2024/2025820 13 9 19 79 42 33 42 212 297 65 9 0
Totale 3.978